Evoke Pharma Inc. (EVOK)
2.79
0.00 (0.00%)
At close: Mar 28, 2025, 3:49 PM
2.78
-0.36%
After-hours: Mar 28, 2025, 05:11 PM EDT
Evoke Pharma Ratios Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
PE Ratio | -0.00 | -0.45 | -1.03 | -1.96 | -4.96 | -5.09 | -5.44 | -2.75 | -1.76 | -1.77 | -2.69 | -6.22 | -7.22 | -5.56 |
PEG Ratio | -0.00 | 0.04 | 0.05 | 0.04 | -0.08 | 0.17 | 0.12 | 0.10 | 0.05 | 0.12 | -0.03 | 0.24 | 0.31 | n/a |
PS Ratio | 0.00 | 0.68 | 3.36 | 10.94 | 2.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.00 | -1.36 | 2.06 | 4.98 | -20.47 | 8.25 | 10.23 | 15.55 | 4.98 | 6.18 | 3.87 | 0.83 | -0.74 | -0.76 |
P/FCF Ratio | -0.00 | -0.7 | -1.28 | -1.43 | -9.92 | -6.27 | -5.9 | -3.86 | -2.17 | -2.04 | -3.1 | -5.8 | -8.32 | -4.62 |
P/OCF Ratio | -0.00 | -0.7 | -1.28 | -1.43 | -9.92 | -6.27 | -5.9 | -3.86 | -2.17 | -2.04 | -3.1 | -5.8 | -8.32 | -4.62 |
OCF/S Ratio | -0.53 | -0.96 | -2.63 | -7.63 | -288.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | -1.94 | 1.26 | 1.41 | -1.63 | 0.03 | n/a | n/a | n/a | 1.26 | 0.48 | 0.14 | -0.05 | n/a |
Quick Ratio | 1.62 | 0.66 | 6.91 | 7.38 | 1.20 | 3.10 | 3.46 | 3.82 | 6.58 | 5.19 | 8.15 | 10.69 | 0.20 | 2.71 |
Current Ratio | 1.66 | 0.71 | 7.08 | 7.51 | 1.23 | 3.10 | 3.46 | 3.82 | 6.58 | 5.19 | 8.15 | 10.69 | 0.20 | 2.71 |
Asset Turnover | 0.59 | 0.73 | 0.21 | 0.15 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 10.38 | -14.86 | -15.57 | -16.3 | -115.47 | n/a | -526.83 | -1.72K | -39.34 | n/a | -121.95 | -16.27 | -83.29 | -840.73 |
Return on Equity (ROE) | -0.76 | 3.02 | -2 | -2.54 | 4.13 | -1.62 | -1.88 | -5.65 | -2.84 | -3.5 | -1.44 | -0.13 | 0.10 | 0.14 |
Return on Assets (ROA) | -0.31 | -1.1 | -0.69 | -0.85 | -1.41 | -1.11 | -1.34 | -1.54 | -1.16 | -1.27 | -0.87 | -0.11 | -17.39 | -2.65 |
Return on Capital (ROIC) | -0.73 | 2.88 | -0.76 | -0.89 | -6.87 | -1.63 | -1.99 | -1.91 | -1.34 | -1.54 | -0.98 | -0.11 | 4.41 | -4.23 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | 96.10% | 85.24% | 79.72% | -276.68% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -52.22% | -150.41% | -325.36% | -558.03% | -57.61K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -52.22% | -150.41% | -327.83% | -527.66% | -57.14K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -50.77% | -143.44% | -310.37% | -503.79% | -56.68K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -53.26% | -96.22% | -262.93% | -763.43% | -28.8K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -50.77% | -140.76% | -307.9% | -496.76% | -56.65K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |